710597--3/31/2009--AXCESS_INTERNATIONAL_INC/TX

related topics
{stock, price, share}
{personnel, key, retain}
{product, candidate, development}
{competitive, industry, competition}
{loss, insurance, financial}
We have a history of losses and expectation of future losses; uncertainty of future profitability; and limits on operations. We are dependent upon our proprietary technology and its marketability as state of the art. The loss of one or more members of management or key personnel could adversely affect our operations and could lead to loss of clients and proprietary information. We may face substantial competition in attracting and retaining qualified personnel, and may be unable to grow our business if we cannot attract and retain qualified personnel. Because we are significantly smaller and less established than a majority of our competitors, we may lack the financial resources necessary to compete effectively and sustain profitability. We are dependent upon third party manufacturers and suppliers to produce our products. The voting control of Axcess is held by Amphion Group, and other stockholders are unlikely to have any ability to influence the governance or policies of our company. The price of our common stock has been highly volatile and may continue to be highly volatile, which may adversely affect your ability to sell your shares and our ability to raise additional capital.

Full 10-K form ▸

related documents
710597--4/14/2010--AXCESS_INTERNATIONAL_INC/TX
899866--2/23/2009--ALEXION_PHARMACEUTICALS_INC
844161--4/15/2010--CHEROKEE_INC
350077--8/28/2008--WMS_INDUSTRIES_INC_/DE/
1042729--3/13/2007--MERCANTILE_BANK_CORP
1279695--3/28/2008--UNIVERSAL_BIOSENSORS_INC
855874--3/9/2009--TRI_COUNTY_FINANCIAL_CORP_/MD/
6292--3/31/2009--ANALYSTS_INTERNATIONAL_CORP
1407161--3/31/2010--Titanium_Asset_Management_Corp
870069--4/16/2010--REGAN_HOLDING_CORP
6292--2/25/2010--ANALYSTS_INTERNATIONAL_CORP
1436083--7/20/2009--New_Millennium_Products
704172--10/13/2010--PHI_GROUP_INC
1101026--4/14/2010--HEALTH_ENHANCEMENT_PRODUCTS_INC
854398--12/14/2007--XATA_CORP_/MN/
1415813--1/12/2010--ASIARIM_CORP
1127703--2/25/2009--PROASSURANCE_CORP
1099932--3/16/2009--CENTRA_FINANCIAL_HOLDINGS_INC
1077428--2/19/2010--TEXAS_CAPITAL_BANCSHARES_INC/TX
844161--4/13/2009--CHEROKEE_INC
821899--9/14/2010--TERRACE_VENTURES_INC
1175416--8/28/2009--STERLING_GROUP_VENTURES_INC
1386926--3/2/2009--KKR_Financial_Holdings_LLC
1136463--1/29/2010--FIRST_CORP_/CN/
1402394--9/20/2010--Bow_Valley_Ventures_Inc.
1072725--3/31/2010--GOLD_RESERVE_INC
1077428--2/19/2009--TEXAS_CAPITAL_BANCSHARES_INC/TX
920465--3/31/2009--LA_JOLLA_PHARMACEUTICAL_CO
890926--3/3/2010--RADIAN_GROUP_INC
1013554--3/31/2009--PARK_BANCORP_INC